Wells Fargo Upgrades Sutro Biopharma to Overweight, Raises PT to $27.

martes, 24 de marzo de 2026, 8:32 am ET1 min de lectura
BLDR--
STRO--
WFC--

Wells Fargo Upgrades Sutro Biopharma to Overweight, Raises PT to $27.

Wells Fargo Upgrades Sutro Biopharma to Overweight, Raises PT to $27.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios